You are here

Article Text

Article menu
Download PDFPDF
Rare disease
CASE REPORT
Bone marrow metastases in salivary duct carcinoma of the parotid gland
  1. Ameya Asarkar1,
  2. Amol Takalkar2,
  3. Manish Dhawan3 and
  4. Cherie Ann O Nathan1
  1. 1 Department of Otolaryngology/HNS, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA
  2. 2 Center for Molecular Imaging and Therapy, Biomedical Research Foundation of Northwest Louisiana, Shreveport, Louisiana, USA
  3. 3 Oncology Associates of Northwest Louisiana, Highland Clinic, Shreveport, Louisiana, USA
  1. Correspondence to Dr Cherie Ann O Nathan, cnatha{at}lsuhsc.edu

Abstract

Salivary duct carcinoma (SDC) is a rare and extremely aggressive salivary gland cancer. An 81-year-old woman with SDC underwent a total parotidectomy with facial nerve sacrifice and a neck dissection. Following surgery, she was diagnosed with disseminated bone marrow metastases. She underwent chemotherapy and trastuzumab for palliation. We present a case of SDC of the parotid which was diagnosed with disseminated bone marrow metastasis following surgery for the primary. This case also highlights the importance of having a high index of suspicion while evaluating highly aggressive tumours like SDC for any atypical findings during workup.

  • ear, nose and throat/otolaryngology
  • head and neck cancer

https://doi.org/10.1136/bcr-2018-226636

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors AA, AT, MD and CAON were responsible for conceptualising and reporting the case. AT and CAON were responsible for final approval of the manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.